BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23083607)

  • 1. Integrated quantitative DCE-MRI and DW-MRI to characterize breast lesions.
    Jena A; Taneja S; Mehta SB
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S64-5. PubMed ID: 23083607
    [No Abstract]   [Full Text] [Related]  

  • 2. Co-registration of MR-mammography and X-ray mammography.
    Dietzel M; Baltzer PA; Hopp T; Ruiter NV; Kaiser WA
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S27-9. PubMed ID: 23083591
    [No Abstract]   [Full Text] [Related]  

  • 3. Second-look ultrasound: only for biopsy or more?
    Leung JW
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S87-9. PubMed ID: 23083617
    [No Abstract]   [Full Text] [Related]  

  • 4. Diffusion weighted imaging: a long way to clinical routine.
    Woodhams R; Ozaki M; Hata H; Inoue Y
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S185-7. PubMed ID: 23083584
    [No Abstract]   [Full Text] [Related]  

  • 5. Exploiting sparsity in x-f space for higher spatiotemporal resolution in breast dynamic contrast-enhanced (DCE)-MRI.
    Usman M; Ramsay EA; Siegler P; Plewes DB; Chan RW
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S171-3. PubMed ID: 23083578
    [No Abstract]   [Full Text] [Related]  

  • 6. Diffusion weighted imaging (DWI) of the breast: ready for clinical practice?
    Lehman CD
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S80-1. PubMed ID: 23083614
    [No Abstract]   [Full Text] [Related]  

  • 7. Whole-body MR or PET-CT?
    Schmidt GP
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S142-3. PubMed ID: 23083566
    [No Abstract]   [Full Text] [Related]  

  • 8. Advantages and drawbacks of breast DTI.
    Furman-Haran E; Eyal E; Shapiro-Feinberg M; Nissan N; Grobgeld D; Weisenberg N; Degani H
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S45-7. PubMed ID: 23083598
    [No Abstract]   [Full Text] [Related]  

  • 9. Diffusion weighted imaging with background body signal suppression / T2 image fusion in magnetic resonance mammography for breast cancer diagnosis.
    Nechifor-Boilă IA; Bancu S; Buruian M; Charlot M; Decaussin-Petrucci M; Krauth JS; Nechifor-Boilă AC; Borda A
    Chirurgia (Bucur); 2013; 108(2):199-205. PubMed ID: 23618570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of occult breast lesions detected by magnetic resonance imaging with targeted ultrasound: a prospective study.
    Aracava MM; Chojniak R; Souza JA; Bitencourt AG; Marques EF
    Eur J Radiol; 2014 Mar; 83(3):516-9. PubMed ID: 24440492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic characterization of non-mass lesions on breast MRI using manual and computer assisted methods.
    Vag T; Baltzer PA; Dietzel M; Kaiser WA
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S177-8. PubMed ID: 23083580
    [No Abstract]   [Full Text] [Related]  

  • 13. High-resolution diffusion-weighted MRI plus mammography for detecting clinically occult breast cancers in women with dense breasts.
    Kim HJ; Shin HJ; Baek S; Lee CW; Choi WJ; Chae EY; Cha JH; Kim HH; Moon WK
    Eur J Radiol; 2024 Jun; 175():111440. PubMed ID: 38547744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound.
    Vassiou K; Kanavou T; Vlychou M; Poultsidi A; Athanasiou E; Arvanitis DL; Fezoulidis IV
    Eur J Radiol; 2009 Apr; 70(1):69-76. PubMed ID: 18295425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted MRI as an adjunct to mammography in women under 50 years of age: an initial study.
    Kazama T; Kuroki Y; Kikuchi M; Sato Y; Nagashima T; Miyazawa Y; Sakakibara M; Kaneoya K; Makimoto Y; Hashimoto H; Motoori K; Takano H
    J Magn Reson Imaging; 2012 Jul; 36(1):139-44. PubMed ID: 22359367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metals in MR-mammography: how to deal with it?
    Hargreaves BA; Daniel BL
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S56-8. PubMed ID: 23083602
    [No Abstract]   [Full Text] [Related]  

  • 17. A new contrast in MR mammography by means of chemical exchange saturation transfer (CEST) imaging at 3 Tesla: preliminary results.
    Schmitt B; Zamecnik P; Zaiss M; Rerich E; Schuster L; Bachert P; Schlemmer HP
    Rofo; 2011 Nov; 183(11):1030-6. PubMed ID: 22034086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supine breast MRI and assessment of future clinical applications.
    Siegler P; Ebrahimi M; Holloway CM; Thevathasan G; Plewes DB; Martel A
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S153-5. PubMed ID: 23083571
    [No Abstract]   [Full Text] [Related]  

  • 19. Dedicated PET device for breast PET and MRI/PET correlations.
    Seiler S; Lenkinski RE
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S149-50. PubMed ID: 23083569
    [No Abstract]   [Full Text] [Related]  

  • 20. Breast MR for intraductal masses.
    Harms SE; Harms DE; Pope K; Grear D; Smith-Foley S; Johnson K
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S59-60. PubMed ID: 23083603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.